{
  "ticker": "ATX",
  "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02971953",
  "id": "02971953",
  "pages": 2,
  "price_sensitive": false,
  "date": "20250723",
  "time": "1611",
  "pdf_url": "https://announcements.asx.com.au/asxpdf/20250723/pdf/06m27nsbpzh00n.pdf",
  "summary": "- **Equity Issuance**: 1,000,000 shares issued via exercise of options at $0.135/share (expiry: 5 June 2028).  \n- **Regulatory Disclosure**: Issued under Section 708A(5)(e) without Part 6D.2 disclosure; confirms compliance with ASX reporting obligations.  \n\n*No material trading or capital markets impact identified beyond dilution from option exercise.*  \n\n*(Omitted: Pipeline/clinical trial details, unless directly tied to fundraising or regulatory milestones.)*",
  "usage": {
    "prompt_tokens": 1223,
    "completion_tokens": 111,
    "total_tokens": 1334,
    "prompt_tokens_details": null
  },
  "model": "deepseek/deepseek-chat-v3-0324:free",
  "processed_at": "2025-07-23T06:51:52.284816"
}